Report

1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 STUDY SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 INCLUSIONS & EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 40
1.5 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
2.1.1 SECONDARY DATA 42
2.1.2 PRIMARY DATA 43
2.2 MARKET ESTIMATION METHODOLOGY 44
2.2.1 BOTTOM-UP APPROACH 44
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 47
2.2.3 TOP-DOWN APPROACH 47
2.3 MARKET GROWTH RATE PROJECTIONS 48
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 50
2.5 RESEARCH ASSUMPTIONS 51
2.6 RISK ANALYSIS 51
2.7 LIMITATIONS 51
3 EXECUTIVE SUMMARY 53
4 PREMIUM INSIGHTS 57
4.1 CELL-BASED ASSAYS MARKET OVERVIEW 57
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER AND COUNTRY (2023) 58
4.3 CELL-BASED ASSAYS MARKET, BY OFFERING, 2023 59
4.4 CELL-BASED ASSAYS MARKET, BY END USER, 2023 59
4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 63
5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery 63
5.2.1.2 Government support and funding for cell-based research 64
5.2.1.3 Growing efforts to curtail animal-based studies 65
5.2.1.4 Rising prevalence of cancer 65
5.2.1.5 Alliances to accelerate innovations in drug discovery 67
5.2.2 RESTRAINTS 67
5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents 67
5.2.2.2 Lack of standardization of protocols used in cell-based assays 68
5.2.3 OPPORTUNITIES 69
5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine 69
5.2.3.2 Growth opportunities in emerging economies 70
5.2.3.3 Rising adoption of AI in drug discovery and cell analysis 71
5.2.4 CHALLENGES 71
5.2.4.1 Complexities in assay designs 71
5.2.4.2 Shortage of skilled professionals 71
5.3 TECHNOLOGY ANALYSIS 72
5.3.1 KEY TECHNOLOGIES 72
5.3.1.1 Flow Cytometry 72
5.3.1.2 High-throughput screening 73
5.3.1.3 High-content screening 73
5.3.1.4 Label-free detection 73
5.3.2 COMPLEMENTARY TECHNOLOGIES 74
5.3.2.1 Artificial intelligence and machine learning 74
5.3.3 ADJACENT TECHNOLOGIES 74
5.3.3.1 Nanotechnology 74
5.4 SUPPLY CHAIN ANALYSIS 74
5.5 VALUE CHAIN ANALYSIS 76
5.6 PRICING ANALYSIS 77
5.7 ECOSYSTEM ANALYSIS 78
5.7.1 RAW MATERIAL VENDORS 79
5.7.2 PRODUCT/SERVICE VENDORS 79
5.7.3 END USERS 80
5.7.4 REGULATORY BODIES 81
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 81
5.9 PATENT ANALYSIS 82
5.9.1 PATENT METHODOLOGY 82
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024 82
5.9.3 INNOVATION & PATENT APPLICATIONS 83
5.9.4 TOP APPLICANTS 83
5.10 KEY CONFERENCES & EVENTS, 2024-2025 86
5.11 REGULATORY LANDSCAPE 87
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
5.11.2 REGULATORY SCENARIO 91
5.12 PORTER'S FIVE FORCES ANALYSIS 94
5.12.1 THREAT OF NEW ENTRANTS 95
5.12.2 THREAT OF SUBSTITUTES 95
5.12.3 BARGAINING POWER OF SUPPLIERS 95
5.12.4 BARGAINING POWER OF BUYERS 95
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 95
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.13.2 BUYING CRITERIA 97
5.14 INVESTMENT & FUNDING SCENARIO 98
5.15 TRADE ANALYSIS 99
5.16 IMPACT OF AI/GENERATIVE AI ON CELL-BASED ASSAYS MARKET 102
6 CELL-BASED ASSAYS MARKET, BY OFFERING 103
6.1 INTRODUCTION 104
6.2 CONSUMABLES 104
6.2.1 REAGENTS 109
6.2.1.1 High demand for reagents in research applications to propel market growth 109
6.2.2 ASSAY KITS 113
6.2.2.1 Reporter gene assays 117
6.2.2.1.1 Versatility of reporter gene assays and widespread applications to fuel growth 117
6.2.2.2 Cell growth assays 121
6.2.2.2.1 Rising use of cell viability and cell proliferation assays for assessing cell growth to boost market 121
6.2.2.3 Second messenger assays 125
6.2.2.3.1 Adoption of secondary messenger assays for cell signaling studies to fuel growth 125
6.2.2.4 Cell death assays 129
6.2.2.4.1 Importance of cell death quantification in drug development to favor growth 129
6.2.2.5 Other assay kits 132
6.2.3 MICROPLATES 136
6.2.3.1 Demand for microplates in assay development to drive market 136
6.2.4 CELL LINES 139
6.2.4.1 Immortalized cell lines 143
6.2.4.1.1 Wide use of immortalized cell lines to boost market 143
?
6.2.4.2 Primary cell lines 146
6.2.4.2.1 Advantages in drug development, preclinical research, and other applications to propel market 146
6.2.4.3 Stem cell lines 150
6.2.4.3.1 Rising use in tissue and disease models to fuel adoption 150
6.2.5 PROBES & LABELS 154
6.2.5.1 Growing need for effective cell labeling to boost demand 154
6.2.6 OTHER CONSUMABLES 157
6.3 INSTRUMENTS 161
6.3.1 AUTOMATION IN INSTRUMENTS TO DRIVE SEGMENTAL GROWTH 161
6.4 SERVICES 165
6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH 165
6.5 SOFTWARE 168
6.5.1 INCREASING ADOPTION OF SOFTWARE FOR EFFICIENT DATA ANALYSIS TO DRIVE GROWTH 168
7 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY 172
7.1 INTRODUCTION 173
7.2 FLOW CYTOMETRY 173
7.2.1 WIDE USAGE OF FLOW CYTOMETRY IN CELL-BASED ASSAYS TO DRIVE MARKET 173
7.3 HIGH-THROUGHPUT SCREENING 177
7.3.1 INCREASING INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH 177
7.4 LABEL-FREE DETECTION 180
7.4.1 GROWING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE DEMAND 180
7.5 OTHER TECHNOLOGIES 184
8 CELL-BASED ASSAYS MARKET, BY APPLICATION 187
8.1 INTRODUCTION 188
8.2 DRUG DISCOVERY 188
8.2.1 TOXICITY STUDIES 192
8.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth 192
8.2.2 PHARMACOKINETIC STUDIES 196
8.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays 196
8.2.3 PHARMACODYNAMIC STUDIES 200
8.2.3.1 Advantages of cell-based assays in pharmacodynamics to propel growth 200
8.3 BASIC RESEARCH 204
8.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES 204
?
8.4 GENETIC STUDIES 208
8.4.1 INCREASING FUNDING FOR GENETIC RESEARCH TO DRIVE MARKET 208
8.5 OTHER APPLICATIONS 211
9 CELL-BASED ASSAYS MARKET, BY END USER 215
9.1 INTRODUCTION 216
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 216
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST SHARE OF END-USER MARKET 216
9.3 CONTRACT RESEARCH ORGANIZATIONS 221
9.3.1 GROWING PREFERENCE FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH 221
9.4 ACADEMIC & RESEARCH INSTITUTES 225
9.4.1 RISING FOCUS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE MARKET 225
10 CELL-BASED ASSAYS MARKET, BY REGION 229
10.1 INTRODUCTION 230
10.2 NORTH AMERICA 230
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 231
10.2.2 US 236
10.2.2.1 US to dominate North American cell-based assays market during forecast period 236
10.2.3 CANADA 240
10.2.3.1 Increasing funding and investments to drive market in Canada 240
10.3 EUROPE 243
10.3.1 EUROPE: MACROECONOMIC OUTLOOK 244
10.3.2 GERMANY 248
10.3.2.1 Germany to dominate cell-based assays market in Europe 248
10.3.3 UK 252
10.3.3.1 Growing cancer research funding to increase demand for cell-based assays 252
10.3.4 FRANCE 256
10.3.4.1 Growing biotechnology sector to drive market 256
10.3.5 ITALY 260
10.3.5.1 Growing pharmaceutical industry in Italy to boost market 260
10.3.6 SPAIN 263
10.3.6.1 Rising research activity and increasing number of biotech companies to favor market growth 263
10.3.7 REST OF EUROPE 267
10.4 ASIA PACIFIC 270
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 271
10.4.2 CHINA 276
10.4.2.1 Increasing R&D expenditure to favor market growth 276
10.4.3 JAPAN 280
10.4.3.1 Government initiatives for drug innovation to support market growth 280
10.4.4 INDIA 283
10.4.4.1 Increasing investments in R&D and funding for life science research to propel market 283
10.4.5 AUSTRALIA 287
10.4.5.1 Booming life science sector to propel market 287
10.4.6 SOUTH KOREA 290
10.4.6.1 Increasing strategic alliances to support market growth 290
10.4.7 REST OF ASIA PACIFIC 294
10.5 LATIN AMERICA 298
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 299
10.5.2 BRAZIL 303
10.5.2.1 Brazil to hold largest share of Latin American market 303
10.5.3 MEXICO 307
10.5.3.1 Government support for biopharmaceutical production to support market growth 307
10.5.4 REST OF LATIN AMERICA 310
10.6 MIDDLE EAST 314
10.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK 315
10.6.2 GCC COUNTRIES 318
10.6.2.1 Saudi Arabia 322
10.6.2.1.1 Increasing R&D investments to drive market 322
10.6.2.2 UAE 326
10.6.2.2.1 Investments and support for biopharma sector to offer growth opportunities 326
10.6.2.3 Rest of GCC Countries 330
10.6.3 REST OF MIDDLE EAST 333
10.7 AFRICA 337
10.7.1 RISING NEED FOR EFFECTIVE DIAGNOSTICS TO SUPPORT MARKET GROWTH 337
10.7.2 AFRICA: MACROECONOMIC OUTLOOK 338
11 COMPETITIVE LANDSCAPE 342
11.1 OVERVIEW 342
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 342
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET 342
11.3 REVENUE ANALYSIS 345
11.4 MARKET SHARE ANALYSIS 346
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 348
11.5.1 STARS 348
11.5.2 EMERGING LEADERS 348
11.5.3 PERVASIVE PLAYERS 348
11.5.4 PARTICIPANTS 348
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 350
11.5.5.1 Company footprint 350
11.5.5.2 Offering footprint 351
11.5.5.3 Technology footprint 352
11.5.5.4 Application Footprint 353
11.5.5.5 Region footprint 354
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 355
11.6.1 PROGRESSIVE COMPANIES 355
11.6.2 RESPONSIVE COMPANIES 355
11.6.3 DYNAMIC COMPANIES 355
11.6.4 STARTING BLOCKS 355
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 357
11.7 VALUATION AND FINANCIAL METRICS 359
11.8 BRAND/PRODUCT COMPARISON 360
11.9 COMPETITIVE SCENARIO 361
11.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 361
11.9.2 DEALS 362
11.9.3 EXPANSIONS 363
12 COMPANY PROFILES 364
12.1 INTRODUCTION 364
12.2 KEY PLAYERS 364
12.2.1 DANAHER CORPORATION 364
12.2.1.1 Business overview 364
12.2.1.2 Products/Services offered 365
12.2.1.3 Recent developments 369
12.2.1.3.1 Deals 369
12.2.1.3.2 Expansions 369
12.2.1.4 MnM view 370
12.2.1.4.1 Key strengths 370
12.2.1.4.2 Strategic choices 370
12.2.1.4.3 Weaknesses & competitive threats 370
12.2.2 THERMO FISHER SCIENTIFIC INC. 371
12.2.2.1 Business overview 371
12.2.2.2 Products/Services offered 373
12.2.2.3 Recent developments 377
12.2.2.3.1 Deals 377
12.2.2.3.2 Expansions 377
12.2.2.4 MnM view 378
12.2.2.4.1 Key strengths 378
12.2.2.4.2 Strategic choices 378
12.2.2.4.3 Weaknesses and competitive threats 378
12.2.3 MERCK KGAA 379
12.2.3.1 Business overview 379
12.2.3.2 Products/Services offered 380
12.2.3.3 Recent developments 383
12.2.3.3.1 Deals 383
12.2.3.3.2 Expansions 384
12.2.3.4 MnM view 384
12.2.3.4.1 Key strengths 384
12.2.3.4.2 Strategic choices 384
12.2.3.4.3 Weaknesses and competitive threats 384
12.2.4 BD 385
12.2.4.1 Business overview 385
12.2.4.2 Products/Services offered 386
12.2.4.3 Recent developments 389
12.2.4.3.1 Product launches 389
12.2.4.3.2 Deals 389
12.2.4.4 MnM view 390
12.2.4.4.1 Key strengths 390
12.2.4.4.2 Strategic choices 390
12.2.4.4.3 Weaknesses and competitive threats 390
12.2.5 AGILENT TECHNOLOGIES, INC. 391
12.2.5.1 Business overview 391
12.2.5.2 Products/Services offered 392
12.2.5.3 Recent developments 393
12.2.5.3.1 Product launches 393
12.2.5.4 MnM view 394
12.2.5.4.1 Key strengths 394
12.2.5.4.2 Strategic choices 394
12.2.5.4.3 Weaknesses & competitive threats 394
12.2.6 LONZA 395
12.2.6.1 Business overview 395
12.2.6.2 Products/Services offered 397
12.2.6.3 Recent developments 398
12.2.6.3.1 Deals 398
12.2.6.3.2 Expansions 398
12.2.7 EUROFINS SCIENTIFIC 399
12.2.7.1 Business overview 399
12.2.7.2 Products/Services offered 400
12.2.7.3 Recent developments 402
12.2.7.3.1 Deals 402
?
12.2.8 CHARLES RIVER LABORATORIES 403
12.2.8.1 Business overview 403
12.2.8.2 Products/services offered 404
12.2.8.3 Recent developments 406
12.2.8.3.1 Service launches 406
12.2.8.3.2 Deals 406
12.2.9 BIO-RAD LABORATORIES, INC. 408
12.2.9.1 Business overview 408
12.2.9.2 Products/Services offered 410
12.2.10 REVVITY 411
12.2.10.1 Business overview 411
12.2.10.2 Products/Services offered 412
12.2.10.3 Recent developments 414
12.2.10.3.1 Product launches 414
12.2.11 SARTORIUS AG 415
12.2.11.1 Business overview 415
12.2.11.2 Products/Services offered 416
12.2.11.3 Recent developments 417
12.2.11.3.1 Expansions 417
12.2.12 CORNING INCORPORATED 418
12.2.12.1 Business overview 418
12.2.12.2 Products/Services offered 419
12.2.13 PROMEGA CORPORATION 420
12.2.13.1 Business overview 420
12.2.13.2 Products/Services offered 420
12.2.14 CELL SIGNALING TECHNOLOGY, INC. 422
12.2.14.1 Business overview 422
12.2.14.2 Products/Services offered 422
12.2.15 ENZO BIOCHEM INC. 424
12.2.15.1 Business overview 424
12.2.15.2 Products/Services offered 425
12.2.15.3 Recent developments 427
12.2.15.3.1 Expansions 427
12.2.16 CARNA BIOSCIENCES, INC. 428
12.2.16.1 Business overview 428
12.2.16.2 Products/Services offered 429
12.2.17 INTERTEK GROUP PLC 431
12.2.17.1 Business overview 431
12.2.17.2 Products/services offered 432
12.2.18 BICO 433
12.2.18.1 Business overview 433
12.2.18.2 Products/Services offered 434
12.3 OTHER PLAYERS 435
12.3.1 CELL BIOLABS, INC. 435
12.3.2 REACTION BIOLOGY 436
12.3.3 AAT BIOQUEST, INC. 437
12.3.4 PESTKA BIOMEDICAL LABORATORIES, INC. 438
12.3.5 NEUROMICS 439
12.3.6 BPS BIOSCIENCE, INC. 439
12.3.7 BELLBROOK LABS 440
12.3.8 PROFACGEN 441
12.3.9 BMG LABTECH 441
12.3.10 HANUGEN THERAPEUTICS 442
12.3.11 ALTOGEN LABS 443
12.3.12 BIOAGILYTIX 444
13 DISCUSSION GUIDE 445
13.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 450
13.2 CUSTOMIZATION OPTIONS 452
13.3 RELATED REPORTS 452
13.4 AUTHOR DETAILS 453

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 49
TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS 62
TABLE 3 ESTIMATED EXPENDITURE BY US NIH FOR STEM CELL RESEARCH, 2019-2025 64
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2022 VS. 2035 65
TABLE 5 CELL-BASED ASSAYS MARKET: KEY DEVELOPMENTS REPORTED, BY PLAYER 67
TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021-2023 78
TABLE 7 AVERAGE SELLING PRICE FOR CELL-BASED ASSAYS, BY REGION, 2023 78
TABLE 8 CELL-BASED ASSAYS MARKET: ROLE OF RAW MATERIAL VENDORS 79
TABLE 9 CELL-BASED ASSAYS MARKET: ROLE OF PRODUCT/SERVICE VENDORS 80
TABLE 10 CELL-BASED ASSAYS MARKET: ROLE OF END USERS 80
TABLE 11 CELL-BASED ASSAYS MARKET: ROLE OF REGULATORY BODIES 81
TABLE 12 PATENTS FILED, 2014-2024 82
TABLE 13 TOP 20 PATENT OWNERS IN CELL-BASED ASSAYS MARKET, 2014-2024 84
TABLE 14 INDICATIVE LIST OF PATENTS IN CELL-BASED ASSAYS MARKET 85
TABLE 15 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS 86
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 87
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 20 CELL-BASED ASSAYS MARKET: REGULATORY GUIDELINES 91
TABLE 21 CELL-BASED ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS 94
TABLE 22 BUYING CRITERIA FOR CELL-BASED ASSAY PRODUCTS, BY END USER 97
TABLE 23 IMPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES),
2019-2023 (USD THOUSAND) 99
TABLE 24 EXPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES),
2019-2023 (USD THOUSAND) 100
TABLE 25 IMPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS) 100
TABLE 26 EXPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS) 101
TABLE 27 CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 104
TABLE 28 CONSUMABLES OFFERED, BY KEY COMPANY 105
TABLE 29 CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 106
TABLE 30 CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 106
TABLE 31 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 107
TABLE 32 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 107
TABLE 33 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 108
TABLE 34 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 108
TABLE 35 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 108
TABLE 36 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 109
TABLE 37 REAGENTS OFFERED, BY KEY COMPANY 110
TABLE 38 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 110
TABLE 39 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 40 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 41 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 42 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 43 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 112
TABLE 44 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 45 ASSAY KITS OFFERED, BY KEY COMPANY 113
TABLE 46 ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 114
TABLE 47 ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 114
TABLE 48 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 49 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 50 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 115
TABLE 51 LATIN AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 52 MIDDLE EAST: ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 116
TABLE 53 GCC COUNTRIES: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 54 REPORTER GENE ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION) 118
TABLE 55 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 118
TABLE 56 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 119
TABLE 57 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 119
TABLE 58 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 120
TABLE 59 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 120
TABLE 60 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 120
TABLE 61 CELL GROWTH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 62 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 122
TABLE 63 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 64 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 65 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 124
TABLE 66 MIDDLE EAST: CELL GROWTH ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 124
TABLE 67 GCC COUNTRIES: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 124
TABLE 68 SECONDARY MESSENGER ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 126
TABLE 69 NORTH AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 70 EUROPE: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 127
TABLE 71 ASIA PACIFIC: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 127
TABLE 72 LATIN AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 128
TABLE 73 MIDDLE EAST: SECONDARY MESSENGER ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 128
TABLE 74 GCC COUNTRIES: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 75 CELL DEATH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION) 129
TABLE 76 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 130
TABLE 77 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 78 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 131
TABLE 79 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 131
TABLE 80 MIDDLE EAST: CELL DEATH ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 131
TABLE 81 GCC COUNTRIES: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 132
TABLE 82 OTHER ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 133
TABLE 83 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 133
TABLE 84 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 85 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 134
TABLE 86 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 135
TABLE 87 MIDDLE EAST: OTHER ASSAY KITS MARKET, BY REGION,
2022-2029 (USD MILLION) 135
TABLE 88 GCC COUNTRIES: OTHER ASSAY KITS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 135
TABLE 89 MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION) 136
TABLE 90 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 137
TABLE 91 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 92 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 93 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 138
TABLE 94 MIDDLE EAST: MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION) 138
TABLE 95 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 139
TABLE 96 CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 140
TABLE 97 CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 98 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 99 EUROPE: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 100 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 101 LATIN AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 102 MIDDLE EAST: CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION) 142
TABLE 103 GCC COUNTRIES: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 104 IMMORTALIZED CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION) 143
TABLE 105 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 144
TABLE 106 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 144
TABLE 107 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 145
TABLE 108 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 145
TABLE 109 MIDDLE EAST: IMMORTALIZED CELL LINES MARKET, BY REGION,
2022-2029 (USD MILLION) 146
TABLE 110 GCC COUNTRIES: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 146
TABLE 111 PRIMARY CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION) 147
TABLE 112 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 148
TABLE 113 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 148
TABLE 114 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 149
TABLE 115 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 149
TABLE 116 MIDDLE EAST: PRIMARY CELL LINES MARKET, BY REGION,
2022-2029 (USD MILLION) 149
TABLE 117 GCC COUNTRIES: PRIMARY CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 150
TABLE 118 STEM CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION) 151
TABLE 119 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 151
TABLE 120 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 121 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 152
TABLE 122 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 153
TABLE 123 MIDDLE EAST: STEM CELL LINES MARKET, BY REGION,
2022-2029 (USD MILLION) 153
TABLE 124 GCC COUNTRIES: STEM CELL LINES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 153
TABLE 125 PROBES & LABELS MARKET, BY REGION, 2022-2029 (USD MILLION) 155
TABLE 126 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 155
TABLE 127 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 128 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 156
TABLE 129 LATIN AMERICA: PROBES & LABELS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 156
TABLE 130 MIDDLE EAST: PROBES & LABELS MARKET, BY REGION,
2022-2029 (USD MILLION) 156
TABLE 131 GCC COUNTRIES: PROBES & LABELS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 157
TABLE 132 OTHER CONSUMABLES OFFERED, BY KEY COMPANY 157
TABLE 133 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION) 158
TABLE 134 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 158
TABLE 135 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 159
TABLE 136 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 159
TABLE 137 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 160
TABLE 138 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION,
2022-2029 (USD MILLION) 160
TABLE 139 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 160
TABLE 140 INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 162
TABLE 141 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 163
TABLE 142 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 143 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 144 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 164
TABLE 145 MIDDLE EAST: INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 164
TABLE 146 GCC COUNTRIES: INSTRUMENTS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 164
TABLE 147 SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 165
TABLE 148 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 149 EUROPE: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 150 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 151 LATIN AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 152 MIDDLE EAST: SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 167
TABLE 153 GCC COUNTRIES: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 154 SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 168
TABLE 155 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 156 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 157 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 170
TABLE 158 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 170
TABLE 159 MIDDLE EAST: SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION) 170
TABLE 160 GCC COUNTRIES: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 161 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 173
TABLE 162 CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION,
2022-2029 (USD MILLION) 174
TABLE 163 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2022-2029 (USD MILLION) 174
TABLE 164 EUROPE: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 165 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 166 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2022-2029 (USD MILLION) 176
TABLE 167 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY REGION, 2022-2029 (USD MILLION) 176
TABLE 168 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2022-2029 (USD MILLION) 176
TABLE 169 CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION) 177
TABLE 170 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 178
TABLE 171 EUROPE: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING,
BY COUNTRY, 2022-2029 (USD MILLION) 178
TABLE 172 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 173 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 174 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION) 180
TABLE 175 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION) 180
TABLE 176 CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION,
2022-2029 (USD MILLION) 181
TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY COUNTRY, 2022-2029 (USD MILLION) 181
TABLE 178 EUROPE: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY COUNTRY, 2022-2029 (USD MILLION) 182
TABLE 179 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY COUNTRY, 2022-2029 (USD MILLION) 182
TABLE 180 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY COUNTRY, 2022-2029 (USD MILLION) 183
TABLE 181 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY REGION, 2022-2029 (USD MILLION) 183
TABLE 182 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY COUNTRY, 2022-2029 (USD MILLION) 183
TABLE 183 OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION,
2022-2029 (USD MILLION) 184
TABLE 184 NORTH AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 184
TABLE 185 EUROPE: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 185
TABLE 186 ASIA PACIFIC: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 185
TABLE 187 LATIN AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 186
TABLE 188 MIDDLE EAST: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION) 186
TABLE 189 GCC COUNTRIES: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET,
BY COUNTRY, 2022-2029 (USD MILLION) 186
TABLE 190 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 188
TABLE 191 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 192 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 189
TABLE 193 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 190
TABLE 194 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 190
TABLE 195 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 196 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 197 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 192
TABLE 198 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 199 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION,
2022-2029 (USD MILLION) 193
TABLE 200 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 194
TABLE 201 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 194
TABLE 202 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 195
TABLE 203 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 195
TABLE 204 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY REGION, 2022-2029 (USD MILLION) 196
TABLE 205 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 196
TABLE 206 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2022-2029 (USD MILLION) 197
TABLE 207 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 198
TABLE 208 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 198
TABLE 209 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 210 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 211 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES,
BY REGION, 2022-2029 (USD MILLION) 200
TABLE 212 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 213 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION) 201
TABLE 214 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 201
TABLE 215 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 202
TABLE 216 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 202
TABLE 217 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 218 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION) 203
TABLE 219 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 220 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION,
2022-2029 (USD MILLION) 205
TABLE 221 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH,
BY COUNTRY, 2022-2029 (USD MILLION) 205
TABLE 222 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 223 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 224 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION) 207
TABLE 225 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2022-2029 (USD MILLION) 207
TABLE 226 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH,
BY COUNTRY, 2022-2029 (USD MILLION) 207
TABLE 227 CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION,
2022-2029 (USD MILLION) 208
TABLE 228 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 208
TABLE 229 EUROPE: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 209
TABLE 230 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 209
TABLE 231 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 232 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2022-2029 (USD MILLION) 210
TABLE 233 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES,
BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 234 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION,
2022-2029 (USD MILLION) 211
TABLE 235 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 236 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 237 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 213
TABLE 238 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 213
TABLE 239 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY REGION, 2022-2029 (USD MILLION) 214
TABLE 240 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022-2029 (USD MILLION) 214
TABLE 241 CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 216
TABLE 242 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION) 217
TABLE 243 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 218
TABLE 244 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 218
TABLE 245 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 219
TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 219
TABLE 247 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 220
TABLE 248 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 220
TABLE 249 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 220
TABLE 250 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION) 222
TABLE 251 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY,
2022-2029 (USD MILLION) 222
TABLE 252 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY,
2022-2029 (USD MILLION) 223
TABLE 253 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY,
2022-2029 (USD MILLION) 223
TABLE 254 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY,
2022-2029 (USD MILLION) 224
TABLE 255 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CROS, BY REGION,
2022-2029 (USD MILLION) 224
TABLE 256 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY,
2022-2029 (USD MILLION) 224
TABLE 257 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2022-2029 (USD MILLION) 225
TABLE 258 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 259 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 260 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 227
TABLE 261 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 227
TABLE 262 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 228
TABLE 263 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 228
TABLE 264 CELL-BASED ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION) 230
TABLE 265 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 233
TABLE 266 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 233
TABLE 267 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 268 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 269 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 270 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 234
TABLE 271 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 235
TABLE 272 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 273 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 236
TABLE 274 US: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 237
TABLE 275 US: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 276 US: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 277 US: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 278 US: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 238
TABLE 279 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 239
TABLE 280 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 281 US: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 239
TABLE 282 CANADA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 240
TABLE 283 CANADA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 284 CANADA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 241
TABLE 285 CANADA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 286 CANADA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 242
TABLE 287 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 242
TABLE 288 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 289 CANADA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 243
TABLE 290 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 245
TABLE 291 EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 245
TABLE 292 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 293 EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 294 EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 295 EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 247
TABLE 296 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 247
TABLE 297 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 248
TABLE 298 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 248
TABLE 299 GERMANY: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 249
TABLE 300 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 249
TABLE 301 GERMANY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 302 GERMANY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 303 GERMANY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 250
TABLE 304 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 251
TABLE 305 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 251
TABLE 306 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 251
TABLE 307 UK: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 253
TABLE 308 UK: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 253
TABLE 309 UK: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 254
TABLE 310 UK: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 254
TABLE 311 UK: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 254
TABLE 312 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 255
TABLE 313 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 314 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 255
TABLE 315 FRANCE: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 257
TABLE 316 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 317 FRANCE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 318 FRANCE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 319 FRANCE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 258
TABLE 320 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 259
TABLE 321 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 259
TABLE 322 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 259
TABLE 323 ITALY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 260
TABLE 324 ITALY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 325 ITALY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 326 ITALY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 327 ITALY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 262
TABLE 328 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 262
TABLE 329 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 330 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 263
TABLE 331 SPAIN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 264
TABLE 332 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 264
TABLE 333 SPAIN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 334 SPAIN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 335 SPAIN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 265
TABLE 336 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 266
TABLE 337 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 338 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 266
TABLE 339 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 267
TABLE 340 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 341 REST OF EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 342 REST OF EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 343 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 269
TABLE 344 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 269
TABLE 345 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 270
TABLE 346 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 270

TABLE 347 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 273
TABLE 348 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 273
TABLE 349 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 350 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 351 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 352 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 275
TABLE 353 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 275
TABLE 354 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 276
TABLE 355 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 276
TABLE 356 CHINA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 277
TABLE 357 CHINA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 358 CHINA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 359 CHINA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 360 CHINA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 278
TABLE 361 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 279
TABLE 362 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 279
TABLE 363 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 279
TABLE 364 JAPAN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 280
TABLE 365 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 366 JAPAN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 367 JAPAN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 368 JAPAN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 282
TABLE 369 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 282
TABLE 370 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 371 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 283
TABLE 372 INDIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 284
TABLE 373 INDIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 374 INDIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 375 INDIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 376 INDIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 285
TABLE 377 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 286
TABLE 378 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 379 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 286
TABLE 380 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 287
TABLE 381 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 382 AUSTRALIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 383 AUSTRALIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 289
TABLE 384 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 289
TABLE 385 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 289
TABLE 386 AUSTRALIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 387 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 290
TABLE 388 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 291
TABLE 389 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 291
TABLE 390 SOUTH KOREA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 391 SOUTH KOREA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 392 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 293
TABLE 393 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 293
TABLE 394 SOUTH KOREA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 294
TABLE 395 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 294
TABLE 396 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 295
TABLE 397 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 295
TABLE 398 REST OF ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 296
TABLE 399 REST OF ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 296
TABLE 400 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 297
TABLE 401 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 297
TABLE 402 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 298
TABLE 403 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 298
TABLE 404 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 299
TABLE 405 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 300
TABLE 406 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 300
TABLE 407 LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 408 LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 409 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 302
TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 302
TABLE 411 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 303
TABLE 412 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 303
TABLE 413 BRAZIL: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 304
TABLE 414 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 304
TABLE 415 BRAZIL: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 305
TABLE 416 BRAZIL: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 305
TABLE 417 BRAZIL: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 305
TABLE 418 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 306
TABLE 419 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 306
TABLE 420 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 306
TABLE 421 MEXICO: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 307
TABLE 422 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 308
TABLE 423 MEXICO: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 308
TABLE 424 MEXICO: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 309
TABLE 425 MEXICO: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 309
TABLE 426 MEXICO: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 309
TABLE 427 MEXICO: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 310
TABLE 428 MEXICO: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 310
TABLE 429 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 311
TABLE 430 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 311
TABLE 431 REST OF LATIN AMERICA: ASSAY KITS MARKET, BY TYPE,
2022-2029 (USD MILLION) 312
TABLE 432 REST OF LATIN AMERICA: CELL LINES MARKET, BY TYPE,
2022-2029 (USD MILLION) 312
TABLE 433 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 313
TABLE 434 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 313
TABLE 435 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 314
TABLE 436 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 314
TABLE 437 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION,
2022-2029 (USD MILLION) 315
TABLE 438 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 315
TABLE 439 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 316
TABLE 440 MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 316
TABLE 441 MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 317
TABLE 442 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 317
TABLE 443 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 317
TABLE 444 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 318
TABLE 445 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 318
TABLE 446 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 319
TABLE 447 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 319
TABLE 448 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 320
TABLE 449 GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 320
TABLE 450 GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 321
TABLE 451 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 321
TABLE 452 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 321
TABLE 453 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 322
TABLE 454 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 322
TABLE 455 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 323
TABLE 456 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 323
TABLE 457 SAUDI ARABIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 324
TABLE 458 SAUDI ARABIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 324
TABLE 459 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 325
TABLE 460 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 325
TABLE 461 SAUDI ARABIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 326
TABLE 462 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 326
TABLE 463 UAE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 327
TABLE 464 UAE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 327
TABLE 465 UAE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 328
TABLE 466 UAE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 328
TABLE 467 UAE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 328
TABLE 468 UAE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 329
TABLE 469 UAE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2022-2029 (USD MILLION) 329
TABLE 470 UAE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 329
TABLE 471 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 330
TABLE 472 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 331
TABLE 473 REST OF GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE,
2022-2029 (USD MILLION) 331
TABLE 474 REST OF GCC COUNTRIES: CELL LINES MARKET, BY TYPE,
2022-2029 (USD MILLION) 332
TABLE 475 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION) 332
TABLE 476 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 332
TABLE 477 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 333
TABLE 478 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 333
TABLE 479 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING,
2022-2029 (USD MILLION) 334
TABLE 480 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE,
2022-2029 (USD MILLION) 334
TABLE 481 REST OF MIDDLE EAST: ASSAY KITS MARKET, BY TYPE,
2022-2029 (USD MILLION) 335
TABLE 482 REST OF MIDDLE EAST: CELL LINES MARKET, BY TYPE,
2022-2029 (USD MILLION) 335
TABLE 483 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 336
TABLE 484 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 336
TABLE 485 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 337
TABLE 486 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER,
2022-2029 (USD MILLION) 337
TABLE 487 AFRICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION) 339
TABLE 488 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION) 339
TABLE 489 AFRICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 490 AFRICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 491 AFRICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY,
2022-2029 (USD MILLION) 340
TABLE 492 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 341
TABLE 493 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 341
TABLE 494 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION) 341
TABLE 495 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 342
TABLE 496 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION 347
TABLE 497 CELL-BASED ASSAYS MARKET: OFFERING FOOTPRINT 351
TABLE 498 CELL-BASED ASSAYS MARKET: TECHNOLOGY FOOTPRINT 352
TABLE 499 CELL-BASED ASSAYS MARKET: APPLICATION FOOTPRINT 353
TABLE 500 CELL-BASED ASSAYS MARKET: REGION FOOTPRINT 354
TABLE 501 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 357
TABLE 502 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 358
TABLE 503 CELL-BASED ASSAYS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024 361
TABLE 504 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2021-AUGUST 2024 362
TABLE 505 CELL-BASED ASSAYS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024 363
TABLE 506 DANAHER CORPORATION: COMPANY OVERVIEW 364
TABLE 507 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 365
TABLE 508 DANAHER CORPORATION DEALS, JANUARY 2021-AUGUST 2024 369
TABLE 509 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024 369
TABLE 510 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 371
TABLE 511 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 373
TABLE 512 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024 377
TABLE 513 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024 377
TABLE 514 MERCK KGAA: COMPANY OVERVIEW 379
TABLE 515 MERCK KGAA: PRODUCTS/SERVICES OFFERED 380
TABLE 516 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2024 383
TABLE 517 MERCK KGAA (GERMANY): EXPANSIONS, JANUARY 2021-AUGUST 2024 384
TABLE 518 BD: BUSINESS OVERVIEW 385
TABLE 519 BD: PRODUCTS/SERVICES OFFERED 386
TABLE 520 BD: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024 389
TABLE 521 BD: DEALS, JANUARY 2021-AUGUST 2024 389
TABLE 522 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 391
TABLE 523 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 392
TABLE 524 AGILENT TECHNOLOGIES, INC.: PRODUCTS LAUNCHES,
JANUARY 2021-AUGUST 2024 393
TABLE 525 LONZA: COMPANY OVERVIEW 395
TABLE 526 LONZA: PRODUCTS/SERVICES OFFERED 397
TABLE 527 LONZA: DEALS, JANUARY 2021-AUGUST 2024 398
TABLE 528 LONZA: EXPANSIONS, JANUARY 2021-AUGUST 2024 398
TABLE 529 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 399
TABLE 530 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 400
TABLE 531 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-AUGUST 2024 402
TABLE 532 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 403
TABLE 533 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 404
TABLE 534 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES,
JANUARY 2021-AUGUST 2024 406
TABLE 535 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-AUGUST 2024 406
TABLE 536 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 408
TABLE 537 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 410
TABLE 538 REVVITY: COMPANY OVERVIEW 411
TABLE 539 REVVITY: PRODUCTS/SERVICES OFFERED 412
TABLE 540 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024 414
TABLE 541 SARTORIUS AG: COMPANY OVERVIEW 415
TABLE 542 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 416
TABLE 543 SARTORIUS AG: EXPANSIONS, JANUARY 2021-AUGUST 2024 417
TABLE 544 CORNING INCORPORATED: COMPANY OVERVIEW 418
TABLE 545 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED 419
TABLE 546 PROMEGA CORPORATION: COMPANY OVERVIEW 420
TABLE 547 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 420
TABLE 548 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 422
TABLE 549 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED 422
TABLE 550 ENZO BIOCHEM INC.: COMPANY OVERVIEW 424
TABLE 551 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED 425
TABLE 552 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024 427
TABLE 553 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW 428
TABLE 554 CARNA BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED 429
TABLE 555 INTERTEK GROUP PLC: COMPANY OVERVIEW 431
TABLE 556 INTERTEK GROUP: PRODUCTS /SERVICES OFFERED 432
TABLE 557 BICO: COMPANY OVERVIEW 433
TABLE 558 BICO: PRODUCTS/SERVICES OFFERED 434